Precigen (PGEN) Interest Expenses (2012 - 2026)
Precigen (PGEN) reported Interest Expenses of $2.9 million for Q1 2026, up 290700.0% year-over-year from N/an in Q1 2025, and down 1.89% quarter-over-quarter from $3.0 million in Q4 2025.
Precigen (PGEN) Interest Expenses (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Interest Expenses data on file, last reported at $2.9 million in Q1 2026.
- Interest Expenses for Q1 2026 came in at $2.9 million, up 290700.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.8 million (up 135380.0% YoY), and the FY2025 annual result was $3.9 million, up 64350.0% from the prior year.
- Interest Expenses slipped to $2.9 million in Q1 2026 per PGEN's latest filing, from $3.0 million in the prior quarter.
- Over five years, Interest Expenses peaked at $3.0 million in Q4 2025 and troughed at $1000.0 in Q3 2023.
- A 5-year average of $934866.7 and a median of $324000.0 in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2026: Interest Expenses slumped 99.95% in 2023, then jumped 290700.0% in 2026.
- A 5-year view of Interest Expenses shows it stood at $637000.0 in 2022, then sank by 98.9% to $7000.0 in 2023, then plunged by 71.43% to $2000.0 in 2024, then jumped by 148100.0% to $3.0 million in 2025, then fell by 1.89% to $2.9 million in 2026.
- Business Quant data shows PGEN's Interest Expenses at $2.9 million in Q1 2026, $3.0 million in Q4 2025, and $902000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -5.58 Mn |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn | 2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.91 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | 902,000.00 |
| Sep 30, 2025 | 902,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Jun 30, 2023 | 136,000.00 |